Dietary approaches to liver health in young adults
Official title: Interdisciplinary Project on Liver Health With a Focus on Steatotic Changes - Pilot Project of the Radiologic Technology, Dietetics, and Biomedical Analysis Programs
Run by Hochschule Campus Wien (University of Applied Sciences Campus Vienna) · NCT07786831 · Data updated 2026-11-12
A 12-week randomized study tests whether a Mediterranean diet or a general healthy diet can improve liver fat and related health measures in young adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 30 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Hochschule Campus Wien (University of Applied Sciences Campus Vienna) Academic / other |
| Locations | 1 site (Vienna, Austria) |
| Status | Recruiting |
| Started | August 31, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07786831 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are university students aged 20–30 with BMI ≤ 39.9 kg/m² who are willing to adhere to a 12-week dietary plan and attend all visits.
✕Probably not a fit
Participants with existing liver disease, heavy alcohol use, implanted devices incompatible with measurements, or other exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective randomized study compares a Mediterranean diet to a generally healthy diet over 12 weeks in young adults. Liver fat and metabolic parameters are measured at baseline, week 6, and week 12 using UGAP ultrasound and standard labs, along with body composition and anthropometrics. The study aims to see how each diet affects liver health and how UGAP relates to laboratory and body composition changes. Participants are university students aged 20 to 30 with BMI up to 39.9 kg/m² and no known liver disease. Safety and feasibility of adherence to the dietary interventions are also observed.
Why it matters
Potential benefit: If successful, the study could identify dietary patterns that help reduce liver fat in young adults.
How similar studies have gone: Previous dietary interventions have shown potential for liver fat reduction with Mediterranean-style diets, but data in young adults using UGAP are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20 to 30 years * Currently enrolled as a student * Body mass index (BMI) ≤ 39.9 kg/m² * Willingness to attend all three study visits at baseline, Week 6, and Week 12 * Willingness to follow the assigned dietary intervention throughout the 12-week study period * Ability to understand the study information and provide written informed consent Exclusion Criteria: * Known acute or chronic liver disease, including non-alcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD) * Acute hepatitis * History of liver transplantation * Excessive alcohol consumption * Heart failure or ascites * Electronic or implanted medical devices that contraindicate bioelectrical impedance analysis (BIA), such as a cardiac pacemaker * Pregnancy * Regular use of medications other than oral contraceptives, including medications with potential hepatotoxic effects * Extreme dietary patterns or use of dietary supplements that may interfere with study outcomes * Unwillingness to follow the assigned dietary intervention or comply with standardized measurement conditions * Inability to provide informed consent
Where it's running
-
Hochschule Campus Wien
Vienna, Austria, Austria Recruiting
Study contacts
- Principal investigator: Agnes Draxler, PhD — Hochschule Campus Wien (University of Applied Sciences Campus Vienna)
- Study coordinator: Daniel Trimmel, MSc
- Email: daniel.trimmel@hcw.ac.at
- Phone: +43 1 606 68 77
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.